Moderators: D. Papadatos - Pastos (UK), F.I. Dimitrakopoulos (GR)
18.30-18.50 GR (17.30-17.50 CET) Liquid Biopsy as a tool for the detection of minimal residual disease - E. Lianidou (GR)
Q&A
18.55-19.15 GR (17.55-18.15 CET ) Circulating Tumor DNA and Minimal Residual Disease in Early-Stage Colorectal Cancer - M. Giannakis (US)
Q&A
19.20-19.40 GR (18.20-18.40 CET) MRD in oncology. The right technology for the right data - N. Tsoulos (GR)
Q&A
19.45-20.05 GR (18.45-19.05 CET) The emerging value of liquid biopsy for the monitoring of MRD in NSCLC - P. Christopoulos (DE)
Q&A
20.10-20.30 GR (19.10-19.30 CET) The importance of liquid biopsy for monitoring of oncogene driven non small cell lung cancer - A. Dimou (US)
Q&A